| Literature DB >> 31807972 |
Akihiko Takeuchi1, Norio Yamamoto2, Katsuhiro Hayashi2, Hidenori Matsubara2, Shinji Miwa2, Kentaro Igarashi2, Hiroyuki Tsuchiya2.
Abstract
The multi-disciplinary approach involving imaging, multi-agent chemotherapy, meticulous surgical procedures, and careful postoperative care has facilitated an increase in the use of limb-sparing surgery for pediatric osteosarcoma. Osteosarcoma usually occurs around the metaphysis of the distal femur or proximal tibia and needs wide excision with the adjacent joint and replacement by a megaprosthesis. The recent advancement in imaging modalities and surgical techniques supports joint-preservation surgery (JPS), involving the preservation of the adjacent epiphysis, for select patients following careful assessment of the tumor margins and precise tumor excision. An advantage of this surgery is that it maintains the adjacent joint and preserves the growth of the residual epiphysis, which provides excellent limb function. Various reconstruction options are available, including allograft, tumor-devitalized autograft, vascularized fibula graft, distraction osteogenesis, and custom-made implants. However, several complications are inevitable with these options, such as loosening, non-union at the host-graft junction, infection, fracture, implant loosening, breakage, deformity, limb-length discrepancy related to the reconstruction methods, or patient growth in pediatric osteosarcoma. Surgeons should fully understand the advantages and disadvantages of this procedure. In this review, we discuss the concept of JPS, types of reconstruction methods, and current treatment outcomes. It is our opinion that the further analysis by multi-institutional setting is necessary to clarify long-term outcomes and establish global guidelines on the indications and surgical procedure for JPS.Entities:
Keywords: Biological reconstruction; Joint-preservation surgery; Knee joint; Pediatric osteosarcoma
Mesh:
Year: 2019 PMID: 31807972 DOI: 10.1007/s10555-019-09835-z
Source DB: PubMed Journal: Cancer Metastasis Rev ISSN: 0167-7659 Impact factor: 9.264